Department of Ophthalmology, Casey Eye Institute at Oregon Health & Science University (OHSU), Portland, Oregon, USA.
Department of Ophthalmology and Visual Sciences, Universidade Federal de São Paulo Escola Paulista de Medicina (UNIFESP), São Paulo, Brazil.
Ophthalmic Genet. 2024 Apr;45(2):167-174. doi: 10.1080/13816810.2023.2245035. Epub 2023 Aug 17.
Variants in HGSNAT have historically been associated with syndromic mucopolysaccharidosis type IIIC (MPSIIIC) but more recent studies demonstrate cases of HGSNAT-related non-syndromic retinitis pigmentosa. We describe and expand the genotypic and phenotypic spectrum of this disease.
This is a retrospective, observational, case series of 11 patients with pericentral retinitis pigmentosa due to variants in HGSNAT gene without a syndromic diagnosis of MPSIIIC. We reviewed ophthalmologic data extracted from medical records, genetic testing, color fundus photos, fundus autofluorescence (FAF), and optical coherence tomography (OCT).
Of the 11 patients, the mean age was 52 years (range: 26-78). The mean age of ophthalmologic symptoms onset was 45 years (range: 15-72). The visual acuity varied from 20/20 to 20/80 (mean 20/30 median 20/20). We described five novel variants in HGSNAT: c.715del (p.Arg239Alafs 37), c.118 G>A (p.Asp40Asn), c.1218_1220delinsTAT, c.1297A>G (p.Asn433Asp), and c.1726 G>T (p.Gly576).
HGSNAT has high phenotypic heterogeneity. Data from our cohort showed that all patients who had at least one variant of c.1843 G>A (p.Ala615Thr) presented with the onset of ocular symptoms after the fourth decade of life. The two patients with onset of ocular symptoms before the fourth decade did not carry this variant. This may suggest that c.1843 G>A variant is associated with a later onset of retinopathy.
HGSNAT 中的变异曾与综合征型黏多糖贮积症 IIIC 型(MPSIIIC)相关,但最近的研究表明存在 HGSNAT 相关的非综合征型视网膜色素变性病例。我们对该病的基因型和表型谱进行了描述和扩展。
这是一项回顾性、观察性、病例系列研究,纳入了 11 例因 HGSNAT 基因突变导致中心旁性视网膜色素变性但无 MPSIIIC 综合征诊断的患者。我们回顾了从病历、基因检测、眼底彩照、眼底自发荧光(FAF)和光学相干断层扫描(OCT)中提取的眼科数据。
11 例患者的平均年龄为 52 岁(范围:26-78 岁)。眼科症状的平均发病年龄为 45 岁(范围:15-72 岁)。视力从 20/20 到 20/80(平均 20/30,中位数 20/20)不等。我们描述了 HGSNAT 中的五个新变异:c.715del(p.Arg239Alafs37)、c.118G>A(p.Asp40Asn)、c.1218_1220delinsTAT、c.1297A>G(p.Asn433Asp)和 c.1726G>T(p.Gly576)。
HGSNAT 具有高度的表型异质性。我们队列的数据表明,所有至少携带一个 c.1843G>A(p.Ala615Thr)变异的患者,其眼部症状的发病年龄都在 40 岁以后。而发病年龄在 40 岁以前的两名患者并未携带该变异。这可能提示 c.1843G>A 变异与视网膜病变的较晚发病相关。